Skip to content

Clinical trials

Amyloidosis trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Country / region: Poland Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20101
20161
20171
20193
20201
20211
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Enrolling by invitation1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals3
Ionis Pharmaceuticals, Inc.2
Alexion Pharmaceuticals, Inc.1
Bellus Health Inc. - a GSK company1
C.T. Development America, Inc.1
Eidos Therapeutics, a BridgeBio company1
Janssen Research & Development, LLC1
John Paul II Hospital, Krakow1
Prothena Biosciences Ltd.1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis13
Cardiomyopathies6
Alzheimer Disease1
Amyloid Neuropathies, Familial1
Amyloidosis, Familial1
Arthritis, Rheumatoid1
Familial Mediterranean Fever1
Gastrointestinal Diseases1
Heart Diseases1
Kidney Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.